Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y1FO
|
||||
Former ID |
DIB008120
|
||||
Drug Name |
Rubitecan
|
||||
Synonyms |
Inhaled Orathecin; L9NC; Rubitecan (inhaled); Aerosolized liposomal 9 nitro-20 (S) camptothecin; Rubitecan (inhaled), SuperGen; 9-Nitro-20(S)-camptothecin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 3 | [521474] | ||
Company |
SuperGen; Clayton Foundation For Research; MD Anderson Cancer Center
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H15N3O6
|
||||
Canonical SMILES |
n12c(c3c(C2)cc2c([N+](=O)[O-])cccc2n3)cc2c(c1=O)COC(=O)<br />[C@]2(O)CC
|
||||
CAS Number |
CAS 91421-42-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Toposisomerase-1 | Target Info | Inhibitor | [527937] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | DNA replication | ||||
Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.